Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

FDA Presents Webinar on Technical Considerations for Additive Manufactured Medical Devices

By Matt Jacobson on January 16, 2018
Email this postTweet this postLike this postShare this post on LinkedIn

On December 5, 2017, the U.S. Food and Drug Administration (FDA) released the final version of its guidance entitled “Technical Considerations for Additive Manufactured Medical Devices; Guidance for Industry and Food and Drug Administration Staff.” As a follow up to the Guidance’s release the FDA held a webinar on January 10, 2017, to present an overview of the Guidance and answer questions. The presentation was a joint effort from several offices within the FDA’s organization and presenters included FDA employees, Matthew Di Prima, James Coburn (both of the Office of Science and Engineering Laboratories), Eric Horowitz (Office of Science and Engineering Laboratories), David Hwang, Joel Anderson (both of the Office of Device Evaluation) and Nooshin Kiarashi (Office of In Vitro Diagnostics and Radiological Health).

The webinar highlighted the technical assessments that manufacturers of certain 3D printed medical devices should consider when submitting a premarket application for a medical device that includes at least one fabrication step using additive manufacturing. As a helpful tool, the FDA used a hypothetical example of a 3D printed cranial implant device to walk through the information that the FDA would require in a premarket application for such a device. FDA has plainly put a lot of time into thinking about the unique technical aspects involved in 3D printing of medical devices and ensuring that the manufacturers of those devices consider these issues when submitting a premarket application.

The slides for the webinar are currently available on the FDA’s website. The webinar was also recorded and should be available here in the near future.

For more about the FDA Guidance, please see: Observations on FDA 3D Printing Guidance and FDA Publishes Draft Guidance Regarding 3D Printing Of Medical Devices. For more on general legal issues involving 3D printed medical devices, please see: 3D Printing of Medical Devices: When a Novel Technology Meets Traditional Legal Principles, 3D Printing of Manufactured Goods: An Updated Analysis, and 3D Printing: What Could Happen to Products Liability When Users (and Everyone Else in Between) Become Manufacturers”.

Photo of Matt Jacobson Matt Jacobson
Read more about Matt JacobsonEmail
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Life Sciences Legal Update
  • Organization:
    Reed Smith LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo